Latest filing published 04 Apr 2023 for Centessa Pharmaceuticals plc, €15k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -82.6%Entry US$21.71 · Close at T+365 US$3.78
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Thomas Templeman: trading record in brief
Thomas Templeman (senior executive) discloses dealings in 2 companies, chiefly Centessa Pharmaceuticals plc and Medivation, Inc. Between 29 September 2015 and 31 March 2023, the trades on record add up to 9 filings.
In open-market terms, that means 1 purchase worth €4,095 on one side and 2 sales worth €18k on the other. Netting one side against the other leaves €14k of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 6 share grants.
Most recently, on 4 April 2023, the filings show a share grant worth €15k in Centessa Pharmaceuticals plc. The most recent open-market purchase was published on 4 June 2021, 1,985 days ago. The median gap between a trade and its publication by SEC (Form 4) is 4 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Thomas Templeman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,103 shares@ US$3.9024.9% of flowOrdinary SharesSEC:0001847903-23-000085:0
- 60,400 shares0Ordinary SharesSEC:0001847903-23-000050:0
- 5,382 shares@ US$4.2539.6% of flowOrdinary SharesSEC:0001847903-23-000030:0
- 2,921 shares@ US$3.1014.4% of flowOrdinary SharesSEC:0001847903-23-000014:0
- 2,455 shares@ US$3.9514.4% of flowOrdinary SharesSEC:0001847903-22-000068:1
- 2,003 shares@ US$4.067414.1% of flowOrdinary SharesSEC:0001847903-22-000068:0
- 140,000 shares0Ordinary SharesSEC:0000899243-22-025472:0
- 250 shares@ US$20.007.0% of flowOrdinary SharesSEC:0000899243-21-022068:0Canonical exit: 31 Aug 2021 (T+90)
- 22,720 shares0Common StockSEC:0001209191-15-072879:0
9 of 9 declarations
